ePrivacy and GPDR Cookie Consent by TermsFeed Generator
×

Home

News

Contact

Archive

Contents

There is a daily increase in the number of patients with malignant diseases, but with the advances in modern oncology research, the number of survivors treated with malignant diseases is becoming larger and larger. The survival rate after completing oncology therapy is increasing on a daily basis, so that malignant diseases belonging to the categor...

By SLAĐANA POPOVIĆ, SRĐAN POPOVIĆ, NIKOLINA DUKIĆ, JELENA VLADIČIĆ-MAŠIĆ, OLIVERA ČANČAR

The human epidermal growth receptor 2 (HER2, c-erb-B2) is present in 15-20% of breast cancer at the time of diagnosis. Overexpression of HER2 receptor is associated with more aggressive form of breast cancer. Trastuzumab is a human monoclonal antibody that blocks the signaling pathways of cell proliferation by binding to the HER2 receptor. Due to t...

By NIKOLINA DUKIĆ, ZDENKA GOJKOVIĆ, NENAD LALOVIĆ, JELENA VLADIČIĆ-MAŠIĆ, DRAGANA JOKANOVIĆ, SRĐAN MAŠIĆ, SLAĐANA POPOVIĆ, OLIVERA ČANČAR